Oncology / cGVHD

Targeting the Biology of Chronic Graft-versus-Host Disease

clinical topic updates by Corey Cutler, MD, MPH, FRCP(C)

The manifestations and severity of chronic graft-versus-host disease (cGVHD) are highly variable and are influenced by cytokines and downstream pat......READ MORE

R R DLBCL

Prospects for Improving Outcomes in High-Risk Diffuse Large B-Cell Lymphoma

expert roundtables by Jeremy S. Abramson, MD, MMSc; Brad Kahl, MD; and Matthew J. Matasar, MD

R R DLBCL

Newer Options for Durable Disease Control in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

expert roundtables by Jeremy S. Abramson, MD, MMSc; Brad Kahl, MD; and Matthew J. Matasar, MD

R R DLBCL

Therapeutic Sequencing in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

expert roundtables by Jeremy S. Abramson, MD, MMSc; Brad Kahl, MD; and Matthew J. Matasar, MD

LATEST IN Oncology

Browse More Articles